Summit Therapeutics (SMMT) Reports Q1 Loss of GBP0.09/Share
Summit Therapeutics (NASDAQ: SMMT) reported Q1 EPS of (GBP0.09), versus (GBP0.06) reported last year.
For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.